Reply to: Dose-escalation of radiation may improve outcomes of squamous cell carcinoma of bladder

被引：0
作者：
Fischer-Valuck, Benjamin W. [1 ,2 ]
Baumann, Brian C. [1 ]
机构：
[1] Washington Univ, Dept Radiat Oncol, St Louis, MO 63110 USA
[2] Emory Univ, Winship Canc Inst, Dept Radiat Oncol, Atlanta, GA 30322 USA
来源：
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY | 2020年 / 20卷
关键词：
THERAPY; CANCER;
D O I：
10.1016/j.ctro.2019.07.004
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：52 / 52
页数：1
相关论文
共 50 条
  • [21] Squamous cell carcinoma of the bladder in a pediatric patient
    Sung, JD
    Koyle, MA
    JOURNAL OF PEDIATRIC SURGERY, 2000, 35 (12) : 1838 - 1839
  • [22] Outcomes of Radiation-Associated Esophageal Squamous Cell Carcinoma: The MSKCC Experience
    Nobel, Tamar B.
    Barbetta, Arianna
    Hsu, Meier
    Tan, Kay See
    Pinchinat, Tiffany
    Schlottmann, Francisco
    Bains, Manjit S.
    Ku, Geoffrey Y.
    Wu, Abraham J.
    Patti, Marco G.
    Jones, David R.
    Molena, Daniela
    JOURNAL OF GASTROINTESTINAL SURGERY, 2019, 23 (01) : 11 - 22
  • [23] Stereotactic Body Radiation Therapy to the Prostate Bed: Results of a Phase 1 Dose-Escalation Trial
    Sampath, Sagus
    Frankel, Paul
    del Vecchio, Bianca
    Ruel, Nora
    Yuh, Bertram
    Liu, An
    Tsai, Tsung
    Wong, Jeffrey
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 106 (03): : 537 - 545
  • [24] Comparisons of the clinical outcomes of different postoperative radiation strategies for treatment of head and neck squamous cell carcinoma
    Makita, Chiyoko
    Kodaira, Takeshi
    Daimon, Takashi
    Tachibana, Hiroyuki
    Tomita, Natsuo
    Koide, Yutaro
    Koide, Yusuke
    Fukuda, Yujiro
    Nishikawa, Daisuke
    Suzuki, Hidenori
    Hanai, Nobuhiro
    Hasegawa, Yasuhisa
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2017, 47 (12) : 1141 - 1150
  • [25] Phase I dose-escalation study of stereotactic body radiotherapy (SBRT) for poor surgical candidates with localized renal cell carcinoma
    Ponsky, Lee
    Lo, Simon S.
    Zhang, Yuxia
    Schluchter, Mark
    Liu, Yiying
    Patel, Ravi
    Abouassaly, Robert
    Welford, Scott
    Gulani, Vikas
    Haaga, John Robert
    Machtay, Mitchell
    Ellis, Rodney J.
    RADIOTHERAPY AND ONCOLOGY, 2015, 117 (01) : 183 - 187
  • [26] Adaptive FDG-PET/CT guided dose escalation in head and neck squamous cell carcinoma: Late toxicity and oncologic outcomes (The ADMIRE study)
    Al-Mamgani, Abrahim
    Kessels, Rob
    Gouw, Zeno A. R.
    Navran, Arash
    Mohan, Vineet
    van de Kamer, Jeroen B.
    Sonke, Jan-Jakob
    V. Vogel, Wouter
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2023, 43
  • [27] Impact of Radiation Dose on Survival for Esophageal Squamous Cell Carcinoma Treated With Neoadjuvant Chemoradiotherapy
    Yang, Yang
    Xu, Xiaofang
    Zhou, Xia
    Bao, Wuan
    Zhang, Danhong
    Gu, Feiying
    Du, Xianghui
    Chen, Qixun
    Qiu, Guoqin
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [28] Phase I dose-escalation study of pazopanib combined with bevacizumab in patients with metastatic renal cell carcinoma or other advanced tumors
    Negrier, Sylvie
    Perol, David
    Bahleda, Rastislav
    Hollebecque, Antoine
    Chatelut, Etienne
    Boyle, Helen
    Cassier, Philippe
    Metzger, Sevrine
    Blanc, Ellen
    Soria, Jean-Charles
    Escudier, Bernard
    BMC CANCER, 2017, 17
  • [29] The effect of dose escalation for large squamous cell carcinomas of the anal canal
    Prasad, R. N.
    Elson, J.
    Kharofa, J.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (10) : 1314 - 1320
  • [30] Influence of dose calculation algorithms on isotoxic dose-escalation of non-small cell lung cancer radiotherapy
    Panettieri, Vanessa
    Malik, Zafar I.
    Eswar, Chinnamani V.
    Landau, David B.
    Thornton, John M. C.
    Nahum, Alan E.
    Mayles, W. Philip M.
    Fenwick, John D.
    RADIOTHERAPY AND ONCOLOGY, 2010, 97 (03) : 418 - 424
12345